Adult Gut Health Test
The Adult Gut Health Test uses shotgun metagenomic sequencing of a stool specimen to describe the adult gut microbiome's taxonomic composition, alpha diversity, key commensal taxa, and inferred functional pathways such as butyrate biosynthesis.
7
Biomarkers
Stool
Sample
15–25 business days
Turnaround
No
Fasting
What is the Adult Gut Microbiome test?
The Adult Gut Health Test applies shotgun metagenomic sequencing to a single stool specimen to describe the composition and inferred functional capacity of the adult gut microbiome. Rather than measuring an analyte concentration, it catalogues which bacteria (and, depending on the pipeline, other microorganisms) are present, estimates their relative abundances, summarises community diversity, and infers the metabolic pathways the community is genetically equipped to carry out. The output is a compositional and functional portrait of the gut ecosystem at one point in time.
In the diagnostic landscape this sits firmly in the exploratory and wellness domain rather than among validated clinical assays. It does not diagnose infection, inflammatory bowel disease, or any specific condition, and it is not a substitute for faecal calprotectin, stool pathogen testing, or endoscopy where those are indicated. Practitioners generally order it to frame dietary and lifestyle conversations, to establish a personal baseline, and to follow change over time on the same platform — with the clear understanding that findings are correlational, method- and pipeline-specific, and of limited individual clinical actionability.
What does the Adult Gut Microbiome test measure?
Alpha diversity summarises how many distinct microbial taxa are present in a single stool specimen and how evenly their relative abundances are distributed. The Shannon index weights both richness and evenness, so a community dominated by a few taxa scores lower than one in which many taxa coexist at comparable abundance. In adults, a more diverse gut community is broadly associated with ecological stability and resilience to perturbation, though diversity is a population-level correlate rather than a mechanistic readout for any one person.
Lower alpha diversity has been reported in association with recurrent antibiotic exposure, restricted dietary patterns, and several chronic conditions, but the relationship is correlational and non-specific. A single diversity score cannot diagnose disease or define an individual's optimum; it is most informative as a longitudinal trend within one person on one platform. Practitioners should treat it as a wellness and research-grade metric rather than a validated clinical endpoint.
Faecalibacterium prausnitzii is one of the most abundant commensal species of the healthy adult colon and a major producer of butyrate through fibre fermentation. Butyrate is a principal energy source for colonocytes and has been studied for roles in epithelial barrier maintenance and mucosal immune signalling. Its relative abundance is sensitive to dietary fibre intake and to colonic conditions such as oxygen tension and pH.
Reduced relative abundance of F. prausnitzii has been reported in inflammatory bowel disease cohorts and other inflammatory states, which has made it a frequently cited marker of a butyrate-producing, 'anti-inflammatory' community. The association is consistent across studies but remains non-diagnostic at the individual level; a low proportion is a prompt for dietary and lifestyle discussion, not a disease label.
Akkermansia muciniphila is a mucin-degrading organism that resides in the colonic mucus layer. By turning over mucin it participates in mucus renewal and has been studied in relation to epithelial barrier function and host metabolic signalling. Its abundance varies widely between healthy individuals and responds to dietary composition, including fibre and polyphenol intake.
Higher relative abundance of A. muciniphila has been associated in observational and interventional studies with favourable metabolic markers, and the organism is an active area of research. Interpretation at the individual level is exploratory: both very low and context-dependent higher proportions have been described, and no clinical decision should rest on this single taxon.
Bifidobacterium is a genus of saccharolytic commensals prominent in early life and retained at lower proportions in the adult colon. Its members ferment host- and diet-derived carbohydrates, contributing to cross-feeding networks that support short-chain fatty acid production. Adult abundance is shaped by diet, transit, and prior antibiotic exposure.
Bifidobacterium is frequently used as a marker of a carbohydrate-fermenting, lactate-cross-feeding community and is among the most common probiotic genera. Lower relative abundance may inform dietary and prebiotic discussion, but the genus-level signal is broad and does not identify a species or strain, so clinical inference is limited.
Proteobacteria is a phylum that includes many facultative anaerobes and several enteric organisms. In a balanced adult colon it usually represents a small minority of reads. Expansion of this phylum has been proposed as a non-specific ecological marker of a perturbed or inflamed gut environment, for example where mucosal oxygen availability favours facultative anaerobes.
A sustained bloom of Proteobacteria is described in the literature as a candidate signature of microbial instability rather than a diagnosis in its own right. It is non-specific and can reflect recent illness, antibiotics, or dietary shifts, so an elevated proportion warrants context and repeat assessment rather than treatment of the number.
The Firmicutes-to-Bacteroidetes ratio is a derived summary of the two phyla that typically dominate the adult gut community. It was popularised by early sequencing studies of body weight and diet, and it shifts with fibre intake, geography, and methodology. It is a coarse compositional descriptor rather than a measure of any single function.
Although widely reported, the F:B ratio has limited and inconsistent clinical validity: studies disagree on its direction of association with obesity and metabolic outcomes, and it is strongly influenced by sequencing method and taxonomic database. It is retained here as a familiar descriptor but should carry little diagnostic weight.
Shotgun metagenomic sequencing recovers microbial genes, allowing the community's functional potential to be inferred — for example the abundance of pathways encoding butyrate and other short-chain fatty acid synthesis. This describes what the community is genetically equipped to do, which is distinct from what it actually produces in vivo, since metabolite output depends on substrate availability, transit, and host uptake.
Higher inferred SCFA and butyrate biosynthesis potential is generally viewed as favourable because short-chain fatty acids support colonocyte energy supply and barrier function. However, inferred potential correlates imperfectly with measured faecal or systemic SCFA, so the metric is a research-grade, exploratory indicator and not a validated functional assay.
Why is the Adult Gut Microbiome test ordered?
- Practitioners establishing a longitudinal microbiome baseline for an adult before and after a defined dietary, fibre, or prebiotic intervention
- Clinicians supporting patients with persistent functional gastrointestinal symptoms after organic disease has been excluded by validated testing
- Functional and integrative practitioners framing personalised nutrition discussions around diversity and fibre-fermenting taxa
- Follow-up assessment of ecological recovery after a course of antibiotics, interpreted as a trend rather than a single snapshot
- Research-oriented or wellness contexts where a compositional and functional overview is explicitly wanted, not a diagnosis
- Patients motivated by self-tracking who understand the exploratory nature of the result and will act chiefly on diet and lifestyle
- Practitioners comparing serial specimens to gauge the directional effect of a sustained dietary change over months
Sample collection and turnaround
Sample type
Stool
Fasting required
No
Collection method
At-home collection kit
Turnaround
15–25 business days
Collection notes
Self-collected at home using the laboratory's stabilised stool kit and returned by prepaid shipping. Record recent antibiotics, probiotics, bowel preparation, and major dietary changes, as each materially affects interpretation. Collection technique and time-to-stabilisation influence which taxa are recovered.
Specimen requirements
Stool collected into the provided DNA-stabilising kit per the manufacturer's instructions, with prompt return. Downstream results depend on sequencing depth and the bioinformatic pipeline; note the kit and laboratory for any serial comparison, as profiles are not portable between platforms.
What can affect Adult Gut Microbiome results?
Antibiotic exposure can sharply lower diversity and deplete susceptible commensals for weeks to months, so a specimen taken soon after a course reflects a perturbed, recovering community rather than a stable baseline.
Fibre, protein, fat, and polyphenol intake shift the relative abundance of fermenting taxa and inferred pathways within days, so short-term dietary changes can move the profile independently of any durable ecological state.
Osmotic purging and bowel prep transiently reshape community structure and abundances; specimens collected soon afterwards are not representative of the habitual microbiome.
Supplemented organisms and fermentable substrates can appear in or shift the profile during use, confounding interpretation of the resident community unless intake is recorded and timed.
Faster or slower transit alters community composition and the Bacteroidetes-to-Firmicutes balance, so transit (e.g. by Bristol stool form) is a recognised confounder of compositional metrics.
Time to preservation, temperature, the stabilising buffer, and the extraction and bioinformatic pipeline each bias which taxa are recovered, so results from different kits or laboratories are not directly comparable.
What do Adult Gut Microbiome results mean?
Elevated
Higher-than-reference relative abundances and higher diversity are read as composition patterns, not as pathology. Greater alpha diversity and higher proportions of fibre-fermenting, butyrate-associated taxa (such as F. prausnitzii) are generally regarded as favourable ecological features. A relative expansion of Proteobacteria, by contrast, is a non-specific instability signal that merits context and repeat sampling rather than treatment of the number.
Normal
A balanced composition with diversity and key taxa within the reference distribution is reassuring but does not exclude gastrointestinal disease, since the profile is not a validated diagnostic of IBD, infection, or malignancy. Symptomatic patients still require the appropriate validated work-up regardless of a reassuring microbiome profile.
Reduced
Lower diversity and depletion of beneficial fermenters describe a less resilient compositional pattern that has been associated at population level with antibiotic exposure, restricted diets, and various chronic conditions. These are correlational signals that can prompt dietary and lifestyle discussion; they do not establish a diagnosis and should not trigger antimicrobial treatment on their own.
Note: Results are compositional and functional-potential descriptors, not measured metabolite levels, and are specific to the sequencing depth, reference database, and bioinformatic pipeline used — values are not interchangeable between laboratories or over time on different platforms. Clinical actionability is limited: most findings are correlational and exploratory. Interpret trends within one person on one platform, correlate with diet, transit, medication, and recent antibiotics, and avoid over-reading any single taxon or ratio.
Frequently asked questions
It uses shotgun metagenomic sequencing of stool to catalogue which microorganisms are present, estimate their relative abundances, summarise community diversity, and infer the metabolic pathways the community is genetically equipped to perform. It describes composition and functional potential, not measured metabolite levels.
How to access the Adult Gut Microbiome test
The Adult Gut Microbiome reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.
Create Free AccountAbout this page
Published: October 7, 2026
Last reviewed: October 7, 2026
- Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. (2012)
- Qin J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. (2010)
- Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. (2016)
- Vujkovic-Cvijin I, et al. Host variables confound gut microbiota studies of human disease. Nature. (verify citation/PMID). (2020)
- Consensus/position statement on the clinical limitations of direct-to-consumer gut microbiome testing. (verify citation/PMID). (2023)
This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.
Related tests
gastrointestinal
CSA + Parasitology
The Comprehensive Stool Analysis + Parasitology — 3 Day is a specialty-laboratory panel combining serial parasitology microscopy, microbial culture, and quantitative digestive markers (calprotectin, secretory IgA, elastase-1, occult blood, short-chain fatty acids, pH).
metabolic diabetes
CMP
The Comprehensive Metabolic Panel is a 14-analyte serum chemistry panel simultaneously evaluating renal function (creatinine, BUN, eGFR), hepatic function (ALT, AST, total bilirubin, albumin, total protein), metabolic status (glucose, calcium), and electrolyte-acid-base homeostasis (sodium, potassium, chloride, bicarbonate) from a single fasting serum specimen.
autoimmune inflammation
CRP
The C-Reactive Protein (CRP) test measures an acute-phase protein produced by the liver in response to inflammatory cytokines, providing a sensitive, rapidly responding marker of inflammation and infection. The standard CRP assay quantifies the higher concentrations of overt inflammation, in contrast to the high-sensitivity (hs-CRP) assay used for cardiovascular risk.